Twist Bioscience Corp. is an innovative synthetic biology company founded in April 2013 and is headquartered in San Francisco, California. Twist is the first company to successfully marry small scale engineering with biology to commercialize silicon-based production of high fidelity and high quality synthetic DNA faster, cheaper and seamlessly. In a relatively short time since its foundation the company has established itself as market leader with 250+ employees and $259M of raised capital to date which should bring it to profitability.
Synthetic DNA has been used for more than five decades in a growing number of applications including drug development, vaccines and antibiotics, diagnostics, chemicals, agriculture and other industrial needs. It also has promise in novel applications like data storage. The company is keen to leverage its high-quality synthetic DNA platform to grow its market potential by vertical integration of some of these applications.
In drug discovery, Twist technology can enable pursuing hard to drug targets, such as GPCR, Ion Channels and transporters. As such, the company is building its own capability and is looking to expand its management to accelerate its growth into drug discovery and development. We are looking for talented executives that are technically astute with understanding of the interface of technology & drug development, have domain knowledge in drug development, and are commercially savvy to be able to establish collaborations with pharma and biotech partners.